Description

ABP-7 Peptide (Actin Binding Peptide-7): Research, Benefits, Mechanisms, and Studies

What Is ABP-7 Peptide?

ABP-7 (Actin Binding Peptide-7) is a synthetic heptapeptide composed of seven amino acids with the sequence Acetyl-LKKTETQ. It is derived from the actin-binding region of TB-500 (Thymosin Beta 4) and is often referred to as a TB-500 fragment.

The LKKTETQ sequence is widely regarded as the primary actin-binding domain within Thymosin Beta 4. Because of this, researchers have shown interest in studying this peptide in areas such as tissue repair, angiogenesis, fibrosis, and cellular regeneration.

ABP-7 is produced using solid-phase peptide synthesis and is designed to replicate the actin-binding activity associated with Thymosin Beta 4 while focusing on its core functional segment.

How ABP-7 Peptide Works

Research suggests that ABP-7 interacts with actin, a key structural protein found throughout the body. Actin is a major component of the cellular cytoskeleton and contributes to several important cellular functions, including:

• Maintaining cell structure and stability
• Supporting cell migration
• Assisting tissue repair processes
• Facilitating intracellular transport
• Participating in cellular signaling

Studies indicate that this peptide may inhibit the conversion of globular actin (G-actin) into filamentous actin (F-actin) through a mechanism known as actin sequestration. By helping maintain actin in its monomeric form, it may influence cell movement, shape changes, and tissue remodeling.

These properties have made it a subject of interest in research involving wound healing, regenerative biology, angiogenesis, and fibrotic conditions.

Chemical Properties

Research and Scientific Studies

Wound Healing and Tissue Repair

One of the primary areas of investigation involves the peptide’s potential role in wound repair and tissue regeneration.

Studies using aged murine models examined whether the actin-binding fragment of Thymosin Beta 4 could reproduce some of the repair-related effects observed with the parent peptide. Findings suggested that the fragment promoted tissue repair responses comparable to those associated with full-length Thymosin Beta 4.

Researchers observed potential improvements in:

• Keratinocyte migration
• Collagen deposition
• Wound closure
• Tissue remodeling

These findings suggest that the peptide may support biological processes involved in tissue repair by encouraging epidermal cells to migrate into damaged areas.

Potential Mechanisms Involved in Wound Repair

Several pathways have been proposed to explain its observed effects.

Purinergic Receptor Activity

Research suggests that ABP 7 peptide may interact with purinergic receptors involved in cellular responses to injury. This interaction could increase intracellular calcium levels, which are important for:

• Cell migration
• Tissue remodeling
• Signaling associated with wound closure

Cytoskeletal Modulation

Because it binds to actin, the peptide may influence cytoskeletal organization and cellular mobility. These effects could contribute to the movement of cells required during tissue repair.

MAP Kinase Pathways

Evidence also suggests possible interactions with MAP kinase signaling pathways, which are involved in regulating cell proliferation, migration, and regenerative responses.

Fibrosis Research

Researchers have explored the potential effects of this peptide on fibrotic processes, particularly in studies involving hepatic stellate cells (HSCs) and liver fibrosis.

Fibrosis occurs when excessive connective tissue accumulates following injury or chronic inflammation. Activated hepatic stellate cells play a central role in this process.

Potential Anti-Fibrotic Activity

Research indicates that the peptide may influence several markers associated with fibrosis, including:

• PDGFβ receptor expression
• Alpha-smooth muscle actin (α-SMA)
• Collagen Type I production

Investigators have also reported possible effects on the Akt signaling pathway, including reduced phosphorylation of:

• Akt T308
• Akt S473
• PRAS40

Since these signaling pathways are involved in cellular growth, migration, and survival, their modulation may affect processes linked to fibrotic tissue formation.

As a result, the peptide continues to be studied as a tool for understanding fibrosis-related cellular mechanisms.

Angiogenesis Research

Another area of interest is angiogenesis, the process through which new blood vessels form.

Studies suggest that the peptide may support several endothelial cell functions involved in vascular development, including:

• Endothelial cell migration
• Tube formation
• Vessel sprouting
• Cellular remodeling

Potential Role in Blood Vessel Formation

Researchers theorize that its actin-binding properties may alter cytoskeletal dynamics within endothelial cells. These structural changes could support the movement and organization of cells required for angiogenesis.

Ex vivo vascular sprouting models have also suggested a potential role in early-stage vessel development, making it relevant to ongoing research in regenerative medicine and vascular biology.

Although the precise molecular mechanisms remain under investigation, current findings indicate that the peptide may influence both cellular architecture and signaling pathways involved in blood vessel formation.

Why Researchers Study ABP-7

L'intérêt porté à ABP-7 découle en grande partie de son interaction avec l'actine et de sa connexion à TB-500 (Thymosin Beta 4).

Les domaines de recherche actuels comprennent :

• Cicatrisation des plaies
• régénération tissulaire
• Fibrose
• Angiogenèse
• Biologie du cytosquelette
• Cell migration

À mesure que les connaissances scientifiques évoluent, les chercheurs utilisent ce peptide pour explorer les mécanismes impliqués dans la réparation tissulaire, le remodelage cellulaire et les processus de régénération.

Foire aux questions

Qu'est-ce que l'ABP-7 ?

L'ABP-7 est un peptide synthétique composé de sept acides aminés dérivés de la région de liaison à l'actine de la thymosine bêta 4. Il est couramment étudié pour ses effets sur la dynamique de l'actine, la réparation tissulaire, l'angiogenèse et les voies liées à la fibrose.

L'ABP-7 est-il identique au TB-500 ?

Non. Bien qu'elle provienne d'une région fonctionnelle spécifique de TB-500 (Thymosin Beta 4)Il ne s'agit pas du peptide complet, mais d'un fragment plus petit contenant la séquence principale de liaison à l'actine.

Comment interagit-il avec l'actine ?

Des recherches suggèrent qu'elle se lie à l'actine et pourrait influencer l'équilibre entre l'actine globulaire (actine G) et l'actine filamenteuse (actine F). Cette interaction pourrait affecter la migration cellulaire, l'organisation du cytosquelette et le remodelage tissulaire.

Quels sont les domaines de recherche qui impliquent ce peptide ?

Les études actuelles ont exploré son rôle potentiel dans :

• Cicatrisation des plaies
• régénération tissulaire
• Angiogenèse
• Recherche sur la fibrose
• Cell migration
• Biologie du cytosquelette

L'ABP-7 peut-il favoriser la cicatrisation des plaies ?

Des études précliniques suggèrent que ce composé pourrait favoriser les processus de réparation tissulaire, notamment la migration des kératinocytes, le dépôt de collagène et le remodelage tissulaire. Des recherches supplémentaires sont nécessaires pour mieux comprendre ses mécanismes d'action et ses applications potentielles.

Est-ce que cette maladie fait l'objet d'études concernant la fibrose ?

Oui. Des chercheurs ont étudié ses effets sur les cellules stellaires hépatiques et les voies de signalisation liées à la fibrose. Les premiers résultats suggèrent qu'il pourrait influencer les marqueurs associés à la formation de tissu fibrotique.

Favorise-t-il l'angiogenèse ?

Les recherches indiquent qu'il pourrait contribuer à la migration des cellules endothéliales, à la formation de tubes et à la néoangiogenèse, autant d'éléments importants du développement de nouveaux vaisseaux sanguins.

L'ABP-7 est-il approuvé pour un usage humain ?

Non. Ce peptide est exclusivement destiné à la recherche scientifique et en laboratoire. Il n'a pas été approuvé pour la consommation humaine, le traitement médical ou l'usage thérapeutique.

Peptide ABP-7 à usage de recherche

Le peptide ABP-7 est exclusivement destiné à la recherche scientifique et en laboratoire. Il n'est pas approuvé pour la consommation humaine ni pour un usage thérapeutique.

Avant de passer commande, veuillez consulter nos conditions générales. Termes et conditions.